Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs Sufentanil for Chronic Postsurgical Pain After VATS
NCT07018375Phase 4Recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Jan 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of oliceridine in chronic postsurgical pain (CPSP), sponsored by Tianjin Medical University General Hospital. Started Jan 2026; status: recruiting.
02
Drugs
oliceridine
03
Conditions
chronic postsurgical pain (CPSP)
Beyond the preview
Go deeper on NCT07018375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07018375.